The first thrombotic event in purely obstetric antiphospholipid syndrome patients and in antiphospholipid antibody carriers: comparison of incidence and characteristics-Reference-Cited by-同舟云学术

The first thrombotic event in purely obstetric antiphospholipid syndrome patients and in antiphospholipid antibody carriers: comparison of incidence and characteristics

Published:2020-09-03 Issue:2 Volume:303 Page:455-461
ISSN:0932-0067
Container-title:Archives of Gynecology and Obstetrics
language:en
Short-container-title:Arch Gynecol Obstet

Author:

Tonello Marta,Calligaro Antonia,Favaro Maria,Del Ross Teresa,Veronese Paola,Salvan Elisa,Gervasi Maria Teresa,Ruffatti Amelia^ORCID

Publisher

Springer Science and Business Media LLC

Subject

Obstetrics and Gynecology,General Medicine

Link

https://link.springer.com/content/pdf/10.1007/s00404-020-05766-1.pdf

Reference21 articles.

1. Miyakis S, Lockshin MD, Atsumi T, Branch DW, Brey RL, Cervera R, Derksen RH, de Groot PG, Koike T, Meroni PL, Reber G, Shoenfeld Y, Tincani A, Vlachoyiannopoulos PG, Krilis SA (2006) International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost 4:295–306. https://doi.org/10.1111/j.1538-7836.2006.01753.x

2. Lassere M, Empson M (2004) Treatment of antiphospholipid syndrome in pregnancy–a systematic review of randomized therapeutic trials. Thromb Res 114:419–426. https://doi.org/10.1016/j.thromres.2004.08.006

3. Ruffatti A, Tonello M, Hoxha A, Sciascia S, Cuadrado MJ, Latino JO, Udry S, Reshetnyak T, Costedoat-Chalumeau N, Morel N, Marozio L, Tincani A, Andreoli L, Haladyj E, Meroni PL, Gerosa M, Alijotas-Reig J, Tenti S, Mayer-Pickel K, Simchen MJ, Bertero MT, De Carolis S, Ramoni V, Mekinian A, Grandone E, Maina A, Serrano F, Pengo V, Khamashta MA (2018) Effect of additional treatments combined with conventional therapies in pregnant patients with high-risk antiphospholipid syndrome: a multicentre study. Thromb Haemost 118:639–646. https://doi.org/10.1055/s-0038-1632388

4. Erkan D, Merrill JT, Yazici Y, Sammaritano L, Buyon JP, Lockshin MD (2001) High thrombosis rate after fetal loss in antiphospholipid syndrome: effective prophylaxis with aspirin. Arthritis Rheum 44:1466–1467. https://doi.org/10.1002/1529-0131(200106)44:6%3C1466:aid-art242%3E3.0.co;2-c

5. Tincani A, Taglietti M, Biasini C, Frassi M, Gorla R, Balestrieri G (2002) Thromboembolicevents after fetal loss in patients with antiphospholipid syndrome: comment on the article by Erkan et al. Arthritis Rheum 46:1126–1127. https://doi.org/10.1002/art.10165

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pregnancy in antiphospholipid syndrome: what should a rheumatologist know?;Rheumatology;2024-02-01

2. Risk factors of first thrombosis in obstetric antiphospholipid syndrome;Lupus Science & Medicine;2024-01

3. Antiphospholipid antibody carriers and patients with quiescent antiphospholipid syndrome show persistent subclinical complement activation;Rheumatology;2023-09-29

4. Interaction between endothelial cell-derived extracellular vesicles and monocytes: A potential link between vascular thrombosis and pregnancy-related morbidity in antiphospholipid syndrome;Autoimmunity Reviews;2023-04

5. Deficiency of Natural Anticoagulants Involves in the Occurrence of Arterial Thrombosis;Plasmatology;2023-01